BC Innovations | Oct 24, 2017
Distillery Therapeutics


INDICATION: Prostate cancer Patient sample, cell culture and mouse studies suggest a mAb against IL-12B monomer could help treat prostate cancer. In patient serum samples, levels of IL-12B monomer were higher than in serum samples...
BC Week In Review | Mar 24, 2014
Clinical News

BNC105: Phase II data

Data from 136 evaluable patients with metastatic RCC who failed prior tyrosine kinase inhibitor (TKI) therapy in the Phase II portion of the open-label, dose-escalation, international Phase I/II DISRUPTOR-1 trial showed that IV BNC105 plus...
Items per page:
1 - 2 of 2